142 related articles for article (PubMed ID: 34241568)
41. Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve.
Kim JH; Lee JH; Lee JH; Hong AR; Kim YJ; Kim YH
World Neurosurg; 2018 Jan; 109():e409-e416. PubMed ID: 29017983
[TBL] [Abstract][Full Text] [Related]
42. Impact of Experience on Outcomes After Endoscopic Transsphenoidal Surgery for Acromegaly.
Goyal-Honavar A; Sarkar S; Asha HS; Kapoor N; Thomas R; Balakrishnan R; Chacko G; Chacko AG
World Neurosurg; 2021 Jul; 151():e1007-e1015. PubMed ID: 34023462
[TBL] [Abstract][Full Text] [Related]
43. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
[TBL] [Abstract][Full Text] [Related]
44. Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations.
Zada G; Cavallo LM; Esposito F; Fernandez-Jimenez JC; Tasiou A; De Angelis M; Cafiero T; Cappabianca P; Laws ER
Neurosurg Focus; 2010 Oct; 29(4):E8. PubMed ID: 20887133
[TBL] [Abstract][Full Text] [Related]
45. Outcome of surgical intrasellar growth hormone tumor performed by a pituitary specialist surgeon in a developing country.
Gondim JA; Ferraz T; Mota I; Studart D; Almeida JP; Gomes E; Schops M
Surg Neurol; 2009 Jul; 72(1):15-9; discussion 19. PubMed ID: 18440607
[TBL] [Abstract][Full Text] [Related]
46. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.
Negm HM; Al-Mahfoudh R; Pai M; Singh H; Cohen S; Dhandapani S; Anand VK; Schwartz TH
J Neurosurg; 2017 Aug; 127(2):397-408. PubMed ID: 27791524
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of trans-sphenoidal surgery in pituitary GH-secreting micro- and macroadenomas: a comparison between microsurgical and endoscopic approach.
Lenzi J; Lapadula G; D'amico T; Delfinis CP; Iuorio R; Caporlingua F; Mecca N; Mercuri V; Bassotti G; Rillo M; Santoro F; Tamburrano G; Santoro A; Gargiulo P
J Neurosurg Sci; 2015 Mar; 59(1):11-8. PubMed ID: 25658052
[TBL] [Abstract][Full Text] [Related]
48. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
[TBL] [Abstract][Full Text] [Related]
49. Significance of postoperative fluid diuresis in patients undergoing transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Zada G; Sivakumar W; Fishback D; Singer PA; Weiss MH
J Neurosurg; 2010 Apr; 112(4):744-9. PubMed ID: 19698049
[TBL] [Abstract][Full Text] [Related]
50. The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes.
Buliman A; Tataranu LG; Ciubotaru V; Cazac TL; Dumitrache C
J Med Life; 2016; 9(2):187-92. PubMed ID: 27453753
[TBL] [Abstract][Full Text] [Related]
51. Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly.
Nishioka H; Fukuhara N; Yamaguchi-Okada M; Takeshita A; Takeuchi Y; Yamada S
Endocr J; 2017 Nov; 64(11):1073-1078. PubMed ID: 28835593
[TBL] [Abstract][Full Text] [Related]
52. Endoscopic endonasal transsphenoidal treatment for acromegaly: 2010 consensus criteria for remission and predictors of outcomes.
Yildirim AE; Sahinoglu M; Divanlioglu D; Alagoz F; Gurcay AG; Daglioglu E; Okay HO; Belen AD
Turk Neurosurg; 2014; 24(6):906-12. PubMed ID: 25448208
[TBL] [Abstract][Full Text] [Related]
53. Endoscopic endonasal transsphenoidal surgery for pituitary adenomas.
Pinar E; Yuceer N; Imre A; Guvenc G; Gundogan O
J Craniofac Surg; 2015 Jan; 26(1):201-5. PubMed ID: 25469897
[TBL] [Abstract][Full Text] [Related]
54. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients.
Shimon I; Cohen ZR; Ram Z; Hadani M
Neurosurgery; 2001 Jun; 48(6):1239-43; discussion 1244-5. PubMed ID: 11383725
[TBL] [Abstract][Full Text] [Related]
55. Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications.
Wilson TJ; McKean EL; Barkan AL; Chandler WF; Sullivan SE
Pituitary; 2013 Dec; 16(4):459-64. PubMed ID: 23307479
[TBL] [Abstract][Full Text] [Related]
56. Transsphenoidal Surgery for Mixed Pituitary Gangliocytoma-Adenomas.
Shepard MJ; Elzoghby MA; Ghanim D; Lopes MBS; Jane JA
World Neurosurg; 2017 Dec; 108():310-316. PubMed ID: 28887280
[TBL] [Abstract][Full Text] [Related]
57. Multidisciplinary Approach for Acromegaly: A Single Tertiary Center's Experience.
Haliloglu O; Kuruoglu E; Ozkaya HM; Keskin FE; Gunaldi O; Oz B; Gazioglu N; Kadioglu P; Tanriover N
World Neurosurg; 2016 Apr; 88():270-276. PubMed ID: 26806060
[TBL] [Abstract][Full Text] [Related]
58. Surgical management of growth hormone-secreting pituitary adenomas: A retrospective analysis of 33 patients.
Zheng Y; Chen DM; Wang Y; Mai RK; Zhu ZF
Medicine (Baltimore); 2020 May; 99(19):e19855. PubMed ID: 32384430
[TBL] [Abstract][Full Text] [Related]
59. Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study.
Coopmans EC; Postma MR; Wolters TLC; van Meyel SWF; Netea-Maier R; van Beek AP; Neggers SJCMM
J Clin Endocrinol Metab; 2021 May; 106(6):1783-1792. PubMed ID: 33544833
[TBL] [Abstract][Full Text] [Related]
60. [Surgical treatment in acromegaly: experience in Córdoba].
Rendón MI; Cecenarro LA; Andrada MC; Barovero MS; Bertolino ML; Cagliolo M; Carpentieri ÁR; Damilano RA; De Battista JC; Estario P; Fernández S; Márquez ME; Monteserin N; Quintero ML; Sala CS; Sosa GA; Surraco ME; De Paul AL; Szafryk de Mereshian P; Fux Otta C
Rev Fac Cien Med Univ Nac Cordoba; 2020 Dec; 77(4):301-306. PubMed ID: 33351372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
